Depression in heart failure

Current Opinion in Cardiology

Volumn 28, Issue 2, 2013, Pages 249-258

  Moudgil, Rohit ^a   Haddad, Haissam ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

cognitive behavioral therapy; depression; heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; BLEEDING; BODY DYSMORPHIC DISORDER; CARDIAC PATIENT; COGNITIVE THERAPY; DEFIBRILLATOR; DEPRESSION; DISEASE EXACERBATION; GYNECOMASTIA; HEART FAILURE; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR DEPRESSION; MENTAL STRESS; MILD COGNITIVE IMPAIRMENT; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SOCIAL STATUS; THYROID DISEASE; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; COSTS AND COST ANALYSIS; DEPRESSION; DISEASE PROGRESSION; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; PREVALENCE; QUALITY OF LIFE;

EID: 84873469241     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32835ced80     Document Type: Review

References (117)

1. Rector TS, Tschumperlin LK, Kubo SH, et al. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail 1995; 1:201-206.
2. Majani G, Pierobon A, Giardini A, et al. Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. Eur Heart J 1999; 20:1579-1586.
3. Dracup K, Walden JA, Stevenson LW, Brecht ML. Quality of life in patients with advanced heart failure. J Heart Lung Transplant 1992; 11:273-279.
4. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics: 2012 update: A report from the American Heart Association. Circulation 2012; 125:e2-e220.
5. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics: 2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: E25-e146.
6. Garrett N, Martini EM. The boomers are coming: A total cost of care model of the impact of population aging on the cost of chronic conditions in the United States. Dis Manag 2007; 10:51-60.
7. Masoudi FA, Havranek EP, Krumholz HM. The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev 2002; 7:9-16.
8. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: The Framingham Heart Study. Circulation 2002; 106:3068-3072.
9. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347:1397-1402.
10. Murberg TA, Bru E, Aarsland T, Svebak S. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med 1998; 28:273-291.
11. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38:199-205.
12. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161:1849-1856.
13. Freedland KE, Rich MW, Skala JA, et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003; 65:119-128.
14. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91:999-1005.
15. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003; 54:216-226.
16. Junger J, Schellberg D, Muller-Tasch T, et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 2005; 7:261-267.
17. Murberg TA, Furze G. Depressive symptoms and mortality in patients with congestive heart failure: A six-year follow-up study. Med Sci Monit 2004; 10:CR643-CR648.
18. Freedland KE, Carney RM, Rich MW. Effect of depression on prognosis in heart failure. Heart Fail Clin 2011; 7:11-21.
19. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270:1819-1825.
20. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom Med 2004; 66:802-813.
21. Thomas SA, Friedmann E, Khatta M, et al. Depression in patients with heart failure: physiologic effects, incidence, and relation to mortality. AACN Clin Issues 2003; 14:3-12.
22. Sullivan M, Simon G, Spertus J, Russo J. Depression-related costs in heart failure care. Arch Intern Med 2002; 162:1860-1866.
23. Guck TP, Elsasser GN, Kavan MG, Barone EJ. Depression and congestive heart failure. Congest Heart Fail 2003; 9:163-169.
24. Cardoso G, Trancas B, Luengo A, Reis D. Heart failure and depression: An association with clinical importance. Rev Port Cardiol 2008; 27:91-109.
25. Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics 2009; 123:1223-1228.
26. Berg AO. Screening for depression: Recommendations and rationale. Am J Nurs 2002; 102:77-80.
27. Havranek EP, Spertus JA, Masoudi FA, et al. Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 2004; 44:2333-2338.
28. Williams SA, Kasl SV, Heiat A, et al. Depression and risk of heart failure among the elderly: A prospective community-based study. Psychosom Med 2002; 64:6-12.
29. Krumholz HM, Butler J, Miller J, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998; 97:958-964.
30. Schotte CK, Maes M, Cluydts R, et al. Construct validity of the Beck Depression Inventory in a depressive population. J Affect Disord 1997; 46:115-125.
31. Johansson P, Dahlstrom U, Brostrom A. The measurement and prevalence of depression in patients with chronic heart failure. Prog Cardiovasc Nurs 2006; 21:28-36.
32. Johansson P, Dahlstrom U, Brostrom A. Consequences and predictors of depression in patients with chronic heart failure: Implications for nursing care and future research. Prog Cardiovasc Nurs 2006; 21:202-211.
33. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571.
34. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 1999; 46:437-443.
35. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965; 12:63-70.
36. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982; 17:37-49.
37. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979; 9:139-145.
38. Upadhyaya AK, Stanley I. Hospital anxiety depression scale. Br J Gen Pract 1993; 43:349-350.
39. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): A diagnostic meta-analysis. J Gen Intern Med 2007; 22:1596-1602.
40. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
41. Asberg M, Montgomery SA, Perris C, et al. A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl 1978; 5-27.
42. Rumsfeld JS, Jones PG, Whooley MA, et al. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J 2005; 150:961-967.
43. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol 1999; 84:348-350; A9.
44. Fulop G, Strain JJ, Stettin G. Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization. Psychosomatics 2003; 44:367-373.
45. Turvey CL, Schultz K, Arndt S, et al. Prevalence and correlates of depressive symptoms in a community sample of people suffering from heart failure. J Am Geriatr Soc 2002; 50:2003-2008.
46. Williams JW Jr, Noel PH, Cordes JA, et al. Is this patient clinically depressed? JAMA 2002; 287:1160-1170.
47. Norra C, Skobel EC, Arndt M, Schauerte P. High impact of depression in heart failure: Early diagnosis and treatment options. Int J Cardiol 2008; 125:220-231.
48. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropinreleasing factor in depression and anxiety disorders. J Endocrinol 1999; 160:1-12.
49. Ehlert U, Gaab J, Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: The role of the hypothalamus-pituitary-adrenal axis. Biol Psychol 2001; 57:141-152.
50. Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol 2001; 21:661-672.
51. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21:293-307.
52. Lake CR, Pickar D, Ziegler MG, et al. High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry 1982; 139:1315-1318.
53. Roy A, Pickar D, De JJ, et al. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamicpituitary- adrenal axis function in depression. Arch Gen Psychiatry 1988; 45:849-857.
54. Wyatt RJ, Portnoy B, Kupfer DJ, et al. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971; 24:65-70.
55. Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 1996; 17:1390-1403.
56. Lombardi F, Mortara A. Heart rate variability and cardiac failure. Heart 1998; 80:213-214.
57. Agelink MW, Boz C, Ullrich H, Andrich J. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res 2002; 113:139-149.
58. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104:2024-2028.
59. McFarlane A, Kamath MV, Fallen EL, et al. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 2001; 142:617-623.
60. Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001; 103:2055-2059.
61. Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000; 102:3060-3067.
62. Raymond RJ, Dehmer GJ, Theoharides TC, Deliargyris EN. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 2001; 141:435-438.
63. MacGowan GA, Mann DL, Kormos RL, et al. Circulating interleukin-6 in severe heart failure. Am J Cardiol 1997; 79:1128-1131.
64. Wollert KC, Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev 2001; 6:95-103.
65. Maes M, Meltzer HY, Bosmans E, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995; 34:301-309.
66. Sluzewska A, Rybakowski J, Bosmans E, et al. Indicators of immune activation in major depression. Psychiatry Res 1996; 64:161-167.
67. Nemeroff CB, Musselman DL. Are platelets the link between depression and ischemic heart disease? Am Heart J 2000; 140:57-62.
68. Folsom AR, Qamhieh HT, Flack JM, et al. Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 1993; 138:1023-1036.
69. Kop WJ, Gottdiener JS, Tangen CM, et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89:419-424.
70. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002; 288:351-357.
71. Ko DT, Hebert PR, Coffey CS, et al. Adverse effects of beta-blocker therapy for patients with heart failure: A quantitative overview of randomized trials. Arch Intern Med 2004; 164:1389-1394.
72. Bennett SJ, Sauve MJ. Cognitive deficits in patients with heart failure: A review of the literature. J Cardiovasc Nurs 2003; 18:219-242.
73. Trojano L, Antonelli Incalzi R, Acanfora D, et al. Cognitive impairment: A key feature of congestive heart failure in the elderly. J Neurol 2003; 250:1456-1463.
74. Zuccala G, Cattel C, Manes-Gravina E, et al. Left ventricular dysfunction: A clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997; 63:509-512.
75. Zuccala G, Onder G, Pedone C, et al. Cognitive dysfunction as a major determinant of disability in patients with heart failure: Results from a multicentre survey. On behalf of the GIFA (SIGG-ONLUS) Investigators. J Neurol Neurosurg Psychiatry 2001; 70:109-112.
76. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC. Cognitive impairment in heart failure: A systematic review of the literature. Eur J Heart Fail 2007; 9:440-449.
77. Carels RA. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res 2004; 13:63-72.
78. Rumsfeld JS, Havranek E, Masoudi FA, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003; 42:1811-1817.
79. Sullivan M, Levy WC, Russo JE, Spertus JA. Depression and health status in patients with advanced heart failure: A prospective study in tertiary care. J Card Fail 2004; 10:390-396.
80. Sullivan MD, Newton K, Hecht J, et al. Depression and health status in elderly patients with heart failure: A 6-month prospective study in primary care. Am J Geriatr Cardiol 2004; 13:252-260.
81. Abramson J, Berger A, Krumholz HM, Vaccarino V. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 2001; 161:1725-1730.
82. Dunbar SB, Kimble LP, Jenkins LS, et al. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999; 9:163-168.
83. Nair N, Farmer C, Gongora E, Dehmer GJ. Commonality between depression and heart failure. Am J Cardiol 2012; 109:768-772.
84. Gottlieb SS, Kop WJ, Ellis SJ, et al. Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]). Am J Cardiol 2009; 103:1285-1289.
85. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry 1999; 156:1007-1013.
86. Hollon SD, Shelton RC, Loosen PT. Cognitive therapy and pharmacotherapy for depression. J Consult Clin Psychol 1991; 59:88-99.
87. Robinson LA, Berman JS, Neimeyer RA. Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research. Psychol Bull 1990; 108:30-49.
88. Beck AT, Hollon SD, Young JE, et al. Treatment of depression with cognitive therapy and amitriptyline. Arch Gen Psychiatry 1985; 42:142-148.
89. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs. medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62:409-416.
90. Hollon SD, DeRubeis RJ, Evans MD, et al. Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Arch Gen Psychiatry 1992; 49:774-781.
91. Blackburn IM, Moore RG. Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression. Br J Psychiatry 1997; 171:328-334.
92. Jarrett RB, Schaffer M, McIntire D, et al. Treatment of atypical depression with cognitive therapy or phenelzine: A double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999; 56:431-437.
93. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 1989; 57:414-419.
94. Murphy GE, Carney RM, Knesevich MA, et al. Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression. Psychol Rep 1995; 77:403-420.
95. Steinbrueck SM,Maxwell SE, Howard GS. A meta-analysis of psychotherapy and drug therapy in the treatment of unipolar depression with adults. J Consult Clin Psychol 1983; 51:856-863.
96. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 1998; 49:59-72.
97. Beutler LE, Scogin F, Kirkish P, et al. Group cognitive therapy and alprazolam in the treatment of depression in older adults. J Consult Clin Psychol 1987; 55:550-556.
98. Kovacs M, Rush AJ, Beck AT, Hollon SD. Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. Arch Gen Psychiatry 1981; 38:33-39.
99. Simons AD, Murphy GE, Levine JL, Wetzel RD. Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry 1986; 43:43-48.
100. Blackburn IM, Eunson KM, Bishop S. A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord 1986; 10:67-75.
101. Evans MD, Hollon SD, DeRubeis RJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 1992; 49:802-808.
102. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289:3106-3116.
103. Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297:367-379.
104. Sullivan MJ, Wood L, Terry J, et al. The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): A mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J 2009; 157:84-90.
105. Lane DA, Chong AY, Lip GY. Psychological interventions for depression in heart failure. Cochrane Database Syst Rev 2005; CD003329.
106. O'Hea E, Houseman J, Bedek K, Sposato R. The use of cognitive behavioral therapy in the treatment of depression for individuals with CHF. Heart Fail Rev 2009; 14:13-20.
107. O'Connor CM, Jiang W, Kuchibhatla M, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008; 168:2232-2237.
108. Cohn JB, Wilcox CS, Goodman LI. Antidepressant efficacy and cardiac safety of trimipramine in patients with mild heart disease. Clin Ther 1993; 15:114-126.
109. Roose SP, Glassman AH. Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. J Clin Psychiatry 1994; 55 (Suppl A):83-87.
110. AlvarezWJr, Pickworth KK. Safety of antidepressant drugs in the patient with cardiac disease: A review of the literature. Pharmacotherapy 2003; 23:754-771.
111. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 2000; 108:2-8.
112. Deglin SM, Deglin JM, Chung EK. Drug-induced cardiovascular diseases. Drugs 1977; 14:29-40.
113. Strik JJ, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. PsychosomMed 2000; 62:783-789.
114. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701-709.
115. O'Connor CM, Jiang W, Kuchibhatla M, et al. Safety and efficacy of sertraline for depression in patients with heart failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010; 56:692-699.
116. Jiang W, O'Connor C, Silva SG, et al. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J 2008; 156:437-444.
117. Angermann CE, Gelbrich G, Stork S, et al. Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 2007; 9: 1212-1222.